Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-84.15%Return on Equity
VS
Market
Sector
Industry
History
$ 0.91Close
$ 0.74 - $ 1.31 52-Week Range
Ticker Information
Ticker
CTSOCompany Name
CYTOSORBENTS CORPSector
HealthcareIndustry
Medical DevicesExchange
NASDAQCYTOSORBENTS CORP - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CTSO - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 11.59M | $ -9.75M | -84.15% |
| 3/31/2025 | $ 14.54M | $ -15.84M | -108.92% |
| 12/31/2024 | $ 11.11M | $ -20.72M | -186.54% |
| 9/30/2024 | $ 13M | $ -18.67M | -143.63% |
| 6/30/2024 | $ 16.74M | $ -25.53M | -152.54% |
| 3/31/2024 | $ 18.93M | $ -27.54M | -145.5% |
| 12/31/2023 | $ 23.28M | $ -28.51M | -122.48% |
| 9/30/2023 | $ 18.51M | $ -23.44M | -126.62% |
| 6/30/2023 | $ 24.09M | $ -26.45M | -109.76% |
| 3/31/2023 | $ 28.96M | $ -31.17M | -107.66% |
Key Performance Insights, Last 5 Years
- CYTOSORBENTS CORP's latest trailing twelve months (TTM) ROE stands at -13.85%.
- Over the past 5 years, CYTOSORBENTS CORP's average ROE has been -86.22%.
- The median ROE for CYTOSORBENTS CORP during this period was -99.2%
- CYTOSORBENTS CORP reached its highest ROE over the past 5 years at -9.89%.
- The lowest ROE recorded by CYTOSORBENTS CORP in the same timeframe -186.54%
CYTOSORBENTS CORP's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for CYTOSORBENTS CORP is calculated as follows: Net Inc. Cmn. [ $ -11.11M ] / Equity [ $ 80.23M ]
(=) ROE [ -13.85% ] CTSO - Return on Equity, Last 5 years
-186.54%
Minimum
Dec 31, 2024
-9.89%
Maximum
Dec 31, 2020
-86.22%
Average
-99.2%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.51% with a standard deviation of 22.67%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.14K |
|---|---|
| min | -66.79% |
| max | 73.25% |
| average | 1.51% |
| median | 6.45% |
| std | 22.67% |